HomeDMKPQ • OTCMKTS
add
Adamis Pharmaceuticals Corporation
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 100.35K | -40.48% |
Operating expense | 727.53K | -58.07% |
Net income | -1.18M | 43.87% |
Net profit margin | -1.18K | 5.69% |
Earnings per share | — | — |
EBITDA | -23.58M | 23.04% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.31K | 4,582.95% |
Total assets | 131.31K | 4,582.95% |
Total liabilities | 3.59M | 49.62% |
Total equity | -3.46M | — |
Shares outstanding | 38.84K | — |
Price to book | -0.00 | — |
Return on assets | -898.24% | — |
Return on capital | 226.03% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -1.18M | 43.87% |
Cash from operations | 146.01K | 4,185.23% |
Cash from investing | 3.48M | 1,132.21% |
Cash from financing | -17.50K | -100.03% |
Net change in cash | -22.14M | -619,356.10% |
Free cash flow | -292.80K | 99.10% |
About
Founded
2006
Website
Employees
12
